Drug class
Antimyasthenic Agents
Antimyasthenic agents are a therapeutic class of medications primarily composed of acetylcholinesterase inhibitors, such as pyridostigmine and neostigmine, used for the symptomatic treatment of myasthenia gravis and related neuromuscular junction disorders. Read more about Antimyasthenic Agents
55 drugs in this class 47 manufacturers
Drugs in Antimyasthenic Agents
NEOSTIGMINE METHYLSULFATE
NEOSTIGMINE METHYLSULFATE
NEOSTIGMINE METHYLSULFATE
MESTINON (pyridostigmine bromide)
MESTINON (pyridostigmine bromide)
PYRIDOSTIGMINE BROMIDE ER (pyridostigmine bromide)
MESTINON (pyridostigmine bromide)
PYRIDOSTIGMINE BROMIDE
Antimyasthenic agents are a therapeutic class of medications primarily composed of acetylcholinesterase inhibitors, such as pyridostigmine and neostigmine, used for the symptomatic treatment of myasthenia gravis and related neuromuscular junction disorders.
They exert their therapeutic effect by reversibly inhibiting the enzyme acetylcholinesterase, which slows the enzymatic breakdown of acetylcholine in the synaptic cleft.
This prolongation and accumulation of acetylcholine enhances transmission across compromised neuromuscular junctions, thereby improving skeletal muscle strength and mitigating exertional fatigue.
-
fda.gov
Antimyasthenic agents are a therapeutic class of medications primarily composed of acetylcholinesterase inhibitors, such as pyridostigmine and neostigmine, used for the symptomatic treatment of myasthenia gravis and related neuromuscular junction disorders
-
pharmacyfreak.com
Antimyasthenic agents are a therapeutic class of medications primarily composed of acetylcholinesterase inhibitors, such as pyridostigmine and neostigmine, used for the symptomatic treatment of myasthenia gravis and related neuromuscular junction disorders They exert their therapeutic effect by reversibly inhibiting the enzyme acetylcholinesterase, which slows the enzymatic breakdown of acetylcholine in the synaptic cleft This prolongation and accumulation of acetylcholine enhances transmission ...
-
scribd.com
Antimyasthenic agents are a therapeutic class of medications primarily composed of acetylcholinesterase inhibitors, such as pyridostigmine and neostigmine, used for the symptomatic treatment of myasthenia gravis and related neuromuscular junction disorders
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.